EcoDrugPlus

Bcl2 Related Protein A1

Ensembl ID : ENSDORG00000001404
Gene Symbol: BCL2A1
2 Cross references
133 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSDORG00000005230
Gene Symbol: BCR
4 Cross references
286 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSDORG00000009983
Gene Symbol: BTK
4 Cross references
206 Possible Orthologues:

C-C Motif Chemokine Receptor 1

Ensembl ID : ENSDORG00000024934
Gene Symbol: CCR1
2 Cross references
158 Possible Orthologues:

C-C Motif Chemokine Receptor 2

Ensembl ID : ENSDORG00000024671
Gene Symbol: CCR2
3 Cross references
150 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSDORG00000005598
Gene Symbol: CCR4
4 Cross references
113 Possible Orthologues:

C-C Motif Chemokine Receptor 5

Ensembl ID : ENSDORG00000028609
Gene Symbol: CCR5
3 Cross references
150 Possible Orthologues:

C-X-C Motif Chemokine Receptor 2

Ensembl ID : ENSDORG00000029478
Gene Symbol: CXCR2
4 Cross references
238 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSDORG00000005421
Gene Symbol: CFTR
3 Cross references
217 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSDORG00000014116
Gene Symbol: DNMT1
3 Cross references
212 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSDORG00000012118
Gene Symbol: TOP1
3 Cross references
273 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSDORG00000016054
Gene Symbol: TOP2A
3 Cross references
206 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).